loader2
Partner With Us NRI

Ambalal Sarabhai Enterprises Ltd share Price Today

Company details

48.21
53.95
20.90
70.00
6M Return 12.18%
1Y Return 133.27%
Mkt Cap.(Cr) 382.55
Volume 303,142
Div Yield 0.00%
OI
-
OI Chg %
-
Volume 303,142

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500

Ambalal Sarabhai Enterprises Ltd shares SWOT Analysis

Strengths (7)

  • Growth in Net Profit with increasing Profit Margin (QoQ)
  • Company with Low Debt
  • Increasing Revenue every quarter for the past 3 quarters

Weakness (5)

  • Inefficient use of capital to generate profits - RoCE declining in the last 2 years
  • Inefficient use of shareholder funds - ROE declining in the last 2 years
  • Inefficient use of assets to generate profits - ROA declining in the last 2 years

Opportunity (3)

  • Highest Recovery from 52 Week Low
  • RSI indicating price strength
  • High Volume, High Gain

Threats (2)

  • High PE (PE > 40)
  • Increasing Trend in Non-Core Income

Resistance and support

R1 53.2
R2 56.4
R3 58.9
Pivot

50.69

S1 47.4
S2 45.0
S3 41.7
EMA SMA
47.3
48.0
47.7
44.2
46.5
47.3
50.6
44.2
Delivery and volume
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
ALPHA LEON ENTERPRISES LLP Bulk Purchase 2021-06-18 34.15 447507 BSE
TOPGAIN FINANCE PRIVATE LIMITED Bulk Purchase 2021-06-18 34.82 396891 BSE
TOPGAIN FINANCE PRIVATE LIMITED Bulk Sell 2021-06-18 34.91 847922 BSE
Name Category Shares
SARABHAI HOLDINGS PRIVATE LIMITED PROMOTER 25.19%
YUDHISTHAR INVESTMENTS PVT LTD IVL PROMOTER 0.61%
KOSHALYA INVESTMENTS PVT LTD IVL PROMOTER 0.6%

FINANCIALS

Sales
Operating Profit
Profit after Tax
Equity
Reserves and Surplus
Debt
Sales
Operating Profit
Profit after Tax
PE
Debt/Equity
P BV

Ambalal Sarabhai Enterprises Ltd Stocks COMPARISON

Financials( in Cr) Ambalal Sarabhai Enterprises Ltd Adani Enterprises Ltd Aegis Logistics Ltd Cello World Ltd Redington Ltd
Price 49.92 3,244.05 754.55 847.15 203.85
% Change 1.20 -1.37 1.33 -2.99 -0.85
Mcap Cr 382.55 369,822.02 26,484.71 17,979.15 15,936.46
Revenue TTM Cr 170.28 69,420.18 8,627.21 1,796.70 79,376.78
Net Profit TTM Cr 11.10 475.37 510.70 285.07 1,439.39
PE TTM 67.46 99.49 46.50 54.11 13.06
1 Year Return 133.27 28.02 108.81 7.00 17.02
ROCE 9.82 6.57 17.08 45.20 25.43
ROE 7.76 2.41 17.88 134.44 22.65
INSIDER & INSTITUTIONAL ACTIVITY

Equity Capital: 130.92 Cr FV: 10.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 39,096.78 -22,281.88
LAST 3M 109,317.46 -33,313.91
LAST 6M 173,877.04 36,325.60
LAST 12M 271,641.54 124,224.97

Ambalal Sarabhai Enterprises Ltd Information

Stock PE (TTM)
67.46
Promoter Holding
30.77%
Book Value
17.8947
ROCE
9.82%
ROE
7.76%
Description
  • Ambalal Sarabhai Enterprises Ltd., incorporated on June 5, 1978, houses a range of companies across multi-dimensional businesses. Each subsidiary is a distinct entity contributing its unique expertise and capabilities. It is one of the oldest pharmaceutical health care companies in India, and today through its group companies it manufactures and markets pharmaceutical, molecular diagnostics, and electronics products in India and internationally. ASE`s strength is to lead with cutting edge technology by creating strategic technology tie-ups and collaborative partnerships through our broad national and international networks The Company produces a range of bulk drugs, pharmaceutical preparations and electronic instruments. It operates in two segments, pharmaceuticals and electronics. Pharmaceuticals segment is engaged in manufacture of drugs and formulations. Electronics segment is engaged in manufacture of electronics instruments and services. In the year 1994, the company entered into a technical collaboration with Biobras, Brazil, to manufacture highly purified insulin injections. During the year 1997-98, the company formed a joint venture company, namely Sarabhai Piramal Pharmaceuticals Ltd with Piramal Enterprises Ltd for marketing of certain products under trademarks being used by the company. During the year 1998-99, the company signed agreement with B V Chiron, Netherlands for introducing their anti-cancer drugs in India. During the year 1999-2000, the company entered into an MoU for marketing of products of Oncology products of Chiron Corporation, USA. The Product Division essentially comprising of Sarabai Chemicals Products was transferred to the joint venture company, Sarabhai Piramal Pharmaceuticals Ltd. In September 2008, the company acquired the manufacturing and marketing company, namely Suvik Hitek Pvt. Ltd. The Ethical Division re-launched the products of Suvik and Sarabhai Chemicals in market. Also, the company acquired Systronics (India) Pvt Ltd. During the year 2008-09, the Oncology Division launched two new products viz. Fludagem & Xtinib. Also, the company promoted a company viz. Vovanties Laboratories Pvt Ltd, a pharmaceutical specialist with a vision to establish a state of the art manufacturing facility specializing in Novel Effervescent Drug Delivery System. During the year 2010-11, the Company had transferred and assigned as going concern, the business undertaking of Sarabhai Chemicals Bulk Drug Division to Synbiotics Ltd and Electronics Division comprising of Systronics, Teleradand SERC to Systronics (India) Ltd with effect from October 01, 2010. Sarabhai M Chemicals Ltd, a wholly owned subsidiary company started its Vitamin C coated products manufacturing since August 2019. In June 2023, Asence Pharma Pvt., Ltd. a subsidiary of the Company commenced its new oncology and synthetic API plant at Ranoli, Vadodara.

Registered Address

Shanti Sadan, Mirzapur Road, Ahmedabad, Gujarat, 380001

Tel : 91-79-25507671/25507073
Email : ase:sarabhai.co.in
Website : http://www.ase.life
Registrar

MCS Limited

AGM Date (Month) : Sep
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 500009
NSE Code : AMBASARABH
Book Closure Date (Month) : Sep
BSE Group : X
ISIN : INE432A01017

FAQ’s on Ambalal Sarabhai Enterprises Ltd Shares

You can buy Ambalal Sarabhai Enterprises Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Ambalal Sarabhai Enterprises Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of May 28, 2024 04:01 PM the closing price of Ambalal Sarabhai Enterprises Ltd was Rs.49.92.

Market capitalization or market cap is determined by multiplying the current market price of a company�s shares with the total number of shares outstanding. As of May 28, 2024 04:01 PM, the market cap of Ambalal Sarabhai Enterprises Ltd stood at Rs. 382.55.

The latest PE ratio of Ambalal Sarabhai Enterprises Ltd as of May 28, 2024 04:01 PM is 67.46

The latest PB ratio of Ambalal Sarabhai Enterprises Ltd as of May 28, 2024 04:01 PM is 0.36

The 52-week high of Ambalal Sarabhai Enterprises Ltd share price is Rs. 70.00 while the 52-week low is Rs. 20.90

Download App

Download Our App

Play Store App Store
market app